CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib | Charles Explorer

CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript: Complete molecular response to imatinib

Publikace na Fakulta tělesné výchovy a sportu |

2005

Abstrakt

CML, BCR-ABL, molecular genetics

Osoba